title: Response by Fauchier et al to Letter Regarding Article, "Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?".
authors: Service de Cardiologie Centre Hospitalier Universitaire Trousseau et Faculté de Médecine Université François Rabelais Tours, France.
authors: Laurent
authors: L
authors: Fauchier
authors: Service de Cardiologie Centre Hospitalier Universitaire Trousseau et Faculté de Médecine Université François Rabelais Tours, France.
authors: Arnaud
authors: A
authors: Bisson
authors: University of Birmingham Institute of Cardiovascular Sciences City Hospital Birmingham B18 7QH United Kingdom.
authors: Gregory Y H
authors: GY
authors: Lip
mesh_terms: D000925:Anticoagulants; D001281:Atrial Fibrillation; D006801:Humans; D018570:Risk Assessment; D012307:Risk Factors; D020521:Stroke
chemical_list: D000925:Anticoagulants